galactose has been researched along with mycophenolic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benndorf, R; Greenbaum, LA; Smoyer, WE | 1 |
| Barratt, J; Kim, MJ; Koller, MT; Molyneux, K; Schaub, S; Stampf, S | 1 |
1 review(s) available for galactose and mycophenolic acid
| Article | Year |
|---|---|
Childhood nephrotic syndrome--current and future therapies.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Child; Cyclophosphamide; Cyclosporine; Enzyme Inhibitors; Galactose; Glucocorticoids; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Interleukin-13; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mycophenolic Acid; Nephrotic Syndrome; p38 Mitogen-Activated Protein Kinases; Plasmapheresis; Protein Serine-Threonine Kinases; Receptors, Notch; Ribonucleosides; Rituximab; Signal Transduction; Tacrolimus; Thiazolidinediones; Unfolded Protein Response | 2012 |
1 other study(ies) available for galactose and mycophenolic acid
| Article | Year |
|---|---|
Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
Topics: Antibodies, Monoclonal; Basiliximab; Drug Therapy, Combination; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Immunosuppressive Agents; Kidney; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recombinant Fusion Proteins; Sirolimus; Tacrolimus | 2016 |